Current concepts: large granular lymphocyte leukemia

T Lamy1, T P Loughran

  • 1H. Lee Moffitt Cancer Center and the Veterans' Administration Hospital, Department of Internal Medicine, University of South Florida, Tampa, USA.

Blood Reviews
|March 31, 2000
PubMed

Insights

Large granular lymphocyte (LGL) leukemia, a clonal disorder affecting T-cells or NK-cells, often presents in elderly individuals with symptoms like neutropenia and anemia. Methotrexate can induce remission, but drug resistance is a challenge.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocyte (LGL) disorders are clonal conditions originating from either T-cell or NK-cell lineages.
  • CD3+ T-cell LGL leukemia is the predominant form, typically affecting elderly patients.
  • Clinical manifestations include neutropenia, anemia, and rheumatoid arthritis, with T-cell LGL leukemia often presenting with a CD3+, alphabeta+, CD8+, CD57+ phenotype.

Purpose of the Study:

  • To elucidate the pathogenesis and clinical features of T-cell and NK-cell LGL leukemia.
  • To investigate the role of cytokines and apoptotic pathway defects in LGL leukemia.
  • To explore potential therapeutic strategies and resistance mechanisms in LGL leukemia.

Main Methods:

  • Analysis of LGL phenotypes (e.g., CD3, CD8, CD57).
  • Detection of clonality via T-cell receptor gene rearrangement.
  • Assessment of cytokine expression (IL12, IL15) and apoptotic pathway components (Fas, Fas-Ligand).
  • Evaluation of serologic reactivity (HTLV-I env p21e homology) and drug resistance markers (PgP+/LRP+).

Main Results:

  • T-LGL leukemia, the most common type, affects elderly individuals with symptoms like neutropenia and anemia.
  • NK-cell LGL disorders include aggressive NK LGL leukemia and chronic lymphocytosis.
  • Leukemic LGL cells exhibit resistance to Fas-induced apoptosis and constitutively express Fas/Fas-Ligand; soluble Fas-Ligand may cause neutropenia.
  • Reactivity to HTLV-I env p21e suggests a role for homologous proteins in pathogenesis.
  • Leukemic LGLs express multidrug resistance proteins (PgP+/LRP+), contributing to chemoresistance.

Conclusions:

  • LGL leukemia pathogenesis involves dysregulated apoptosis, potentially linked to cytokines like IL12/IL15 and defective Fas signaling.
  • Low-dose methotrexate can achieve clinical and molecular remission.
  • LGL leukemia serves as a model for understanding how dysregulated apoptosis contributes to malignancy and autoimmune diseases.
  • Multidrug resistance phenotype contributes to treatment challenges in aggressive cases.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...